The dabl Clinical Trials Management System and 24-hour ABPM Device Logistics Services for clinical research

dabl is a globally recognised provider of Ambulatory Blood Pressure Measurement Systems (ABPM), device, logistics and technical support services to multi-site clinical trials where cardiac safety and ambulatory blood pressure endpoints are critical elements of the study Protocol. The dabl Clinical Trials Management System (CTMS) has been developed using Direct Data Capture technologies to provide high quality evaluable blood pressure data to Investigators and Sponsors of a range of studies including Hypertension, Diabetes, Dyslipidemia & Hypoglycaemia, Obesity treatment, Parkinson's Disease, and many other therapeutic studies. To accurately monitor the effects of drug therapies or renal denervation procedures on blood pressure, dabl provides unmatched expertise, from protocol development advice, through to statistical analysis of results for Phase I to IV Clinical Trials.
The system offers a comprehensive range of statistics relating to blood pressure and cardiovascular outcome. Ambulatory Blood Pressure Measurement (ABPM) is used to test anti-hypertensive drug efficacy and as a cardiac safety biomarker in non - Cardiovascular trials. To accurately monitor the effects of drugs or renal denervation procedures on blood pressure, dabl provides unmatched blood pressure expertise, including ABPM, from protocol development advice, through to analysis of results for Phase I to IV Clinical Trials.

Achieves 100% Evaluable Data

Optimising the results of Clinical Trials by delivering up to 100% Evaluable Data

The dabl system provides immediate validation of Blood Pressure Results offering up to 100% Evaluable Data. It is easily configurable to the requirements of each protocol and links to a range of validated blood pressure monitoring devices.

Find out more